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Objective: Our purpose was to evaluate the effect of ventricular septal defect enlargement on the early and late
morbidity and mortality of patients undergoing Rastelli or Rastelli-type operations.
Methods: A total of 49 patients who underwent Rastelli or Rastelli-type operations between 1991 and 2007 were
included in a retrospective follow-up study. Patients were divided into 2 groups: group A had ventricular septal
defect enlargement, and group B did not have ventricular septal defect enlargement for comparison. Risk factor
analysis for early or late death included patient-related and procedure-related variables, with failure, arrhythmia,
and atrioventricular block as outcome parameters.
Results: Median age and weight at the time of the operation were 6 years (range, 3 months–22 years) and 17 kg
(range, 7–48 kg), respectively. The ventricular septal defect was enlarged in 28 (57%) patients. Ventricular septal
defect enlargement showed a significant statistical relation with late ventricular dysfunction, arrhythmia, and re-
sidual ventricular septal defect (P ¼ .023, P ¼ .047, and P ¼ .01, respectively, log-rank test). No relation was
found between ventricular septal defect enlargement and permanent pacemaker implantation (P ¼ .73, log-
rank test). Furthermore, enlargement of the ventricular septal defect did not show any significant effect on the
rate of early mortality (P ¼ .69, Cox regression). Kaplan–Meier estimated survival for patients with ventricular
septal defect enlargement was 74% at 5 years and 65% at 10 years. Freedom from late death in the group without
ventricular septal defect enlargement was 100% at 5 and 10 years and 83% at 15 years. At a median follow-up of
4 years (range, 6 months–16 years), there were 12 late-onset deaths: 11 in group A (n¼ 28) and 1 in group B (n¼
21). Ventricular septal defect enlargement greatly increased the risk of late death (P ¼ .009, Cox regression).
Conclusions: Septal resection in patients undergoing Rastelli or Rastelli-type operations has a substantial effect
on late morbidity and is a predictive factor for long-term mortality.Right ventricle–pulmonary artery conduit interposition, as
described by Rastelli for d-transposition of the great arteries
with ventricular septal defect (VSD) and left ventricular out-
flow tract obstruction (LVOTO), has been used for patients
with a variety of heart defects, such as a double-outlet right
ventricle (DORV) and pulmonary atresia with VSD. There
are several reports regarding the long-term outcome of
pulmonary ventricle–pulmonary artery conduit repair.
However, these reports mainly focused on survival rate,
conduit longevity, and arrhythmia. Little attention was pre-
viously paid to the role of VSD enlargement as one of the
risk factors for early and late morbidity and mortality. Our
aim was to define the influence of VSD enlargement in the
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MATERIALS AND METHODS
All patients who underwent Rastelli or Rastelli-type operations between
1991 and 2007 at our institution were included in a retrospective follow-up
study. Three patients who were lost to follow-up were excluded. We en-
rolled patients with 2 different pathologies in which a Rastelli-type conduit
for right ventricle–pulmonary artery connection was used: complete trans-
position of the great vessels and DORV.
A Rastelli-type operation is attributed to procedures using valved con-
duit for right ventricle–pulmonary artery connection (either a homograft
or xenograft) with an intracardiac baffle (Dacron or polytetrafluoroethylene
patch) of VSD for connecting the left ventricle to the aorta. All patients un-
derwent operations through a midsternotomy. Standard aortobicaval cardio-
pulmonary bypass with moderate hypothermia at 25C and cold antegrade
crystalloid cardioplegia were used. We enlarged the VSD in patients with
restrictive defects according to the preoperative echocardiographic mea-
surements, which were confirmed intraoperatively with Hegars relative to
the aortic valve size by means of direct visualization through a ventriculot-
omy. The VSD was also enlarged in cases with prominent septal malalign-
ment in which defect baffling would not provide a straight nonobstructive
outflow tract (linear flow pattern). It was enlarged by means of incision at
the anterosuperior margin of the defect. Including the morphology of
Fallot-type DORV in our series might establish the assumption that the
subaortic VSD in this group of patients has a significant effect on the
technique of intraventricular rerouting and on the late ventricular outflow
tract obstruction compared with that seen in patients with transposition of
the great arteries morphology. Hence we considered the variable ofrgery c August 2009
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VSD ¼ ventricular septal defect
morphology in the analysis of potential influencing factors for both early
and late mortality.
Patients were divided into 2 groups to evaluate the effect of VSD en-
largement: group A had VSD enlargement, and group B did not have
VSD enlargement for comparison. Early morbidity and mortality were de-
fined as events and death, respectively, within 30 days after the operation.
Early reoperation for residual defects was defined as a procedure within
30 days after the operation. Late outcomes for the study were defined as
events, reoperation, and death or heart transplantation beyond the first 30
days after the Rastelli operation. Early low cardiac output was defined as
the need for 2 postoperative inotropic medications for longer than 30 min-
utes in the intensive care unit to maintain a systolic blood pressure greater
than the lower limit of normal and a cardiac index greater than 2.2 L $
min1 $ m2 after correction of all electrolyte or blood gas abnormalities
and after adjusting the preload to its optimal value. Late ventricular dysfunc-
tion (beyond the first 30 days after the Rastelli operation) was defined as low
ventricular ejection fraction determined by means of echocardiographic
analysis with either the m-mode or Simpson method. The presence of a gra-
dient of 50 mm Hg or greater, as determined by means of echocardiographic
analysis, was considered left or right ventricular outflow tract obstruction
requiring surgical intervention.
Statistical analysis was performed with SPSS software, version 13.0
(SPSS, Inc, Chicago, Ill). All normally distributed data were expressed as
the mean  standard deviation. The significance of difference between
the 2 groups was assessed by using the unpaired Student’s t test, the c2
test, the Fisher’s exact test, or the log-rank test, as appropriate. Survival es-
timates were obtained by using the Kaplan–Meier method. For multivariate
analysis, Cox regression was used to establish the variables independently
predictive of early and late death. Variables with a P value of .1 or less in
univariate analyses were entered as candidates into the Cox regression
model for determining the significant multivariate predictors. The follow-
up status of patients was determined by means of retrospective review of
hospital records or telephone interviews. This study was approved by the
ethics committee of Tehran University of Medical Sciences. Informed con-
sent was obtained for data extracting from patients’ medical files.
RESULTS
A total of 49 patients, including 28 patients with complete
transposition of the great vessels and 21 patients with
DORV, were enrolled in the study. Twenty-eight (57%) pa-
tients had associated pulmonary artery anomalies, including
pulmonary atresia, main pulmonary artery stenosis, branch
pulmonary artery stenosis, and peripheral pulmonary artery
stenosis. The characteristics of patients in groups A and B
are depicted in Table 1. The male–to-female ratio in all pa-
tients was 33:16, and the age at operation ranged from 12
months to 22 years (mean, 6.8 years; median, 6 years).
Nine (18.4%) patients were less than 4 years of age, and
weight at the time of the operation ranged from 7 to 48 kg
(mean, 19 kg; median, 17 kg). Twelve (24.5%) patients
weighed less than 15 kg. Forty (81.6%) patients had a previ-The Journal of Thoracic and Cous palliative procedure, such as modified Blalock–Taussig
shunt, septostomy, septectomy, or central shunt. The mean
cardiopulmonary bypass time was 179 41 minutes (range,
80–344 minutes), and aortic crossclamp time was 98  22
minutes (range, 47–210 minutes). Forty (82% of patients)
homografts and 9 (18% of patients) bovine jugular veins
(Contegra; Medtronic, Inc, Minneapolis, Minn) were used
in the reconstruction of right ventricular outflow tracts. Pa-
tients were divided into 2 groups: group A had VSD enlarge-
ment (28 [57%] patients), and group B did not have VSD
enlargement (21 [43%] patients). The mean of age and
weight at the time of the operation, male–to-female ratio,
morphology, palliative procedure, cardiopulmonary bypass
time, aortic crossclamp time, and type of conduit were not
statistically different between groups A and B (Table 1).
Early-Onset Morbidity
Nineteen (38%) patients had residual VSD: 15 patients in
group A with VSD enlargement and 4 patients in group B
without VSD enlargement. Two (4%) patients, 1 in each
TABLE 1. Comparison of characteristics and perioperative variables
in patients with (group A) and without (group B) VSD enlargement
Variable Group A Group B P value, c2/t test
Patients (frequency) 28 21
Age at the time
of operation, y*
(mean  SD)
7.1  4.1 6.3  3.6 .42
Male/female ratio 21:7 12:9 .19
Weight at the time
of operation, kg*
(mean  SD)
20  7.8 17  7 .18
Morphology 1
Complete transposition
of great arteries
16 12
Double-outlet right
ventricle
12 9
Pulmonary stenosis/atresia 14 14 .24
MPA, LPA, RPA, or
PPA stenosis
11 10 .56
Pulmonary atresia 3 4 .41
Palliative procedure 21 19 .17
Hemoglobin (g/dL) 18.2  4.2 17.8  5.1 .74
Oxygen saturation (%) 70.6  8.1 73.7  7.8 .18
Conduit
Homograft 21 19 .16
Bovine jugular
vein (Contegra)
7 2 .16
Cardiopulmonary bypass
time (min)
181  48 176  30 .7
Aortic crossclamp
time (min)
99  26 95  18 .5
Cardioplegia (times) 5  1.2 4.7  1.6 .49
VSD, Ventricular septal defect; SD, standard deviation; MPA, main pulmonary artery;
LPA, Left pulmonary artery; RPA, right pulmonary artery; PPA, peripheral pulmonary
artery. *Rastelli or Rastelli-type operation.ardiovascular Surgery c Volume 138, Number 2 391
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VSD during the same hospital stay. Early reoperation was
also done for postoperative bleeding in 10 (20%) patients,
tricuspid valve damage in 7 (10%) patients, and residual
LVOTO in 1 (2%) patient. The latter patient was less than
3 years old and in group B. Transient atrioventricular
(AV) block occurred in 4 (8%) patients, 3 in group A and
1 in group B; early low cardiac output occurred in 8
(16%) patients, 6 in group A and 2 in group B; transient ar-
rhythmia occurred in 5 (10%) patients, 4 in group A and 1 in
group B; convulsion occurred in 2 (4%) patients; and infec-
tion occurred in 1 (2%) patient (Table 2). Although residual
VSD was significantly related to the enlargement of the de-
fect (P ¼ .01, log-rank test), early reoperation necessary for
closing a hemodynamically significant residual defect was
performed in only 2 patients (P ¼ 1, Fisher’s exact test).
No relation was found between VSD enlargement and tran-
sient AV block (P¼ .69, Fisher’s exact test). Tricuspid valve
damage requiring early reoperation occurred much more in
group A (6 vs 1), although it could not be confirmed statis-
tically (P ¼ .09, c2 test; Table 2). All tricuspid valves were
repaired without any valve replacement.
TABLE 2. Comparison of early and late morbidity and mortality in
patients with (group A) and without (group B) VSD enlargement
Variable Group A Group B
P value,
c2/log-rank test
Bleeding 7 2 .27
Early low cardiac output 6 2 .44
Residual VSD 15 4 .01
Total reoperation
for residual VSD
5 3 .42
Early reoperation 2 1 1
Late reoperation 3 2 .56
Atrioventricular valve
damage*
6 1 .09
Early residual LVOTO 0 1 1
Late residual LVOTO 1 6 .05
Late residual RVOTO 5 1 .03
Complete atrioventricular
block
6 5 .81
Transient 3 1 .62
Permanent 3 4 .73
Late ventricular
dysfunction
8 1 .023
Arrhythmia 7 1 .047
Early transient
arrhythmia
4 1 .38
Late arrhythmia 3 0 .11
Death 15 1 .001
Early 4 0 .125
Late 11 1 .005
Infection 1 0 1
Neurologic problem 2 0 .5
VSD, Ventricular septal defect; LVOTO, left ventricular outflow tract obstruction;
RVOTO, right ventricular outflow tract obstruction. *Tricuspid valve.392 The Journal of Thoracic and Cardiovascular SuEarly Mortality
Four (8%) early-onset deaths, all in group A, occurred in
the operating room or intensive care unit: 3 patients with
DORV and 1 patient with complete transposition of the great
vessels. The cause of death was low cardiac output in 2
(50%) patients, bleeding in 1 (25%) patient, and sepsis in
1 (25%) patient. The effect of VSD enlargement on the
rate of early mortality could not be shown statistically
(P ¼ .074, log-rank test). By using multivariate Cox regres-
sion analysis, no significant predictor for early death was
found (Table 3).
Late-Onset Morbidity
Late ventricular dysfunction (right ventricle>left ventri-
cle) occurred in 9 patients (20% of all survivors): 8 in group
A and 1 in group B (P ¼ .033, Fisher’s exact test; P ¼ .023,
log-rank test). Three of the 9 patients had late contractility
dysfunction with late right ventricular outflow tract obstruc-
tion caused by conduit stenosis. Late LVOTO was found in
the follow-up of 6 patients in group B (28% of all survivors
in group B) and 1 patient in group A (4% of all survivors in
group A). All patients were noted to have right bundle
branch block. Permanent heart block requiring an implanted
pacemaker occurred in 7 patients (15% of all survivors): 3
TABLE 3. Predictors for early death
Variable No. Event
P value,
univariate
log-rank test
P value,
multivariate*
Cox regression
VSD enlargement 28 4 0.074 .69
Early postoperative
bleeding
11 1 0.723
Atrioventricular valve
damagey
7 0 0.399
Morphology of DORV 21 3 0.04 .71
MPA,LPA, RPA, PPA
stenosis, or PA
28 3 0.45
Age at the time of
operation<4 y
9 3 0.003 .97
Body weight at the time
of operation<15 kg
12 3 0.015 .98
Aortic saturation<69% 17 1 0.615
Total cardiopulmonary
bypass time>190 min
9 3 0.003 .99
Aortic crossclamp time
>100 min
10 3 0.005 .99
Early arrhythmia 5 0 0.486
Early ventricular
dysfunction
8 3 0.001 .30
Transient atrioventricular
block
4 1 0.2
VSD, Ventricular septal defect; DORV, double-outlet right ventricle; MPA, main pul-
monary artery; LPA, left pulmonary artery; RPA, right pulmonary artery; PPA, periph-
eral pulmonary arteries; PA, pulmonary atresia. *Only variables with a univariate P
value of .1 or less were entered as candidates into the Cox model. yTricuspid valve.rgery c August 2009
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Patient
no. Morphology
Palliative
operation
Age at
Rastelli
repair (y)
VSD
enlargement
Reoperation
early
Reoperation
late
Cause of
death
Age at
death (y)
1 TGA Yes 6 Yes AV valve
damage*
No Sudden death
(arrhythmia)
17
2 TGA Yes 13 Yes No Conduit
replacement
Sudden death
(arrhythmia)
28
3 TGA Yes 4 Yes No Conduit
replacement
Ventricular
dysfunction
15
4 DORV Yes 5 Yes No Conduit
replacement
At reoperation
for conduit
replacement
18
5 TGA Yes 10 Yes Bleeding No Severe pneumonia 14
6 DORV Yes 10 Yes No No Sudden death
(arrhythmia)
12
7 DORV Yes 8 Yes Bleeding No Severe pneumonia 12
8 DORV No 5 Yes Residual VSD No Ventricular
dysfunction
5.5
9 TGA Yes 12 Yes Residual VSD No Ventricular
dysfunction
21
10 TGA Yes 7 Yes No No Ventricular
dysfunction
20
11 TGA Yes 5 No No Conduit
replacement
At reoperation
for conduit
replacement
11
12 DORV Yes 5 Yes AV valve
damage
No Ventricular
dysfunction
6
VSD, Ventricular septal defect; TGA, transposition of the great arteries; AV, atrioventricular; DORV, double-outlet right ventricle. *Tricuspid valve.patients in group A, who underwent VSD enlargement, and
4 patients in group B without VSD enlargement. No relation
was found between VSD enlargement and permanent pace-
maker implantation (P¼ .73, log-rank test). Late reoperation
was performed in 5 (11%) patients for closing the residual
VSD and in 9 (20%) patients for conduit replacement. There
was not a significant relation between the enlargement of
VSD and late repair for residual VSD (P ¼ .56, log-rank
test). Freedom from conduit replacement at 5 and 10 years
was 80%  8.4% and 53%  13%, respectively. In 1
(2%) of our patients, redo median sternotomy for homograft
replacement resulted in massive hemorrhage caused by the
rupture of vascular structures adherent to the posterior
sternum.
Late Mortality
At a median follow-up of 4 years (range, 6 months–16
years), there were 12 late deaths. No cardiac transplantation
was done because of the limited supply and facilities in our
country. The causes of late death were sudden death in 3
(25%) patients, ventricular dysfunction in 5 (41%) patients,
reoperation for conduit replacement in 2 (17%) patients, and
severe pneumonia in 2 (17%) patients. Three late deaths
were sudden and unexplained and could have been related
to undiagnosed arrhythmias (Table 4). Eleven patients
with late death had VSD enlargement at the time of RastelliThe Journal of Thoracic andrepair. Statistically, there was a significant relation between
late death and VSD enlargement (P ¼ .005, log-rank test).
Kaplan–Meier estimated survival for group A at 5 and 10
years was 74%  10% and 65%  12%, respectively.
Freedom from late death in group B was 100% at 10 years
and 83%  15% at 15 years. The actuarial survival curves
for all patients and also each group with and without VSD
enlargement are shown in Figures 1 and 2.
Overall, VSD enlargement (P¼ .009, multivariate Cox re-
gression), late ventricular dysfunction (P¼ .039, multivariate
Cox regression), late arrhythmia (P¼ .034, multivariate Cox
regression), pulmonary artery abnormalities (P¼ .035, mul-
tivariate Cox regression), and chronic hypoxemia (P¼ .037,
multivariate Cox regression) were significant predictors of
late death in our patients undergoing Rastelli repair (Table 5).
DISCUSSION
The Rastelli operation in its original description consisted
of directing the left ventricle to the aorta by suturing a Teflon
patch between the VSD and the aortic orifice and of recon-
structing the continuity from the right ventricle to the pulmo-
nary artery with a valved conduit.1 Rastelli suggested
diversion of the left ventricular output through the VSD
into the aorta. Hence the VSD must be adequate in diameter
to allow a completely unobstructed outflow from the left
ventricle. The position of the aorta and the tricuspid valveCardiovascular Surgery c Volume 138, Number 2 393
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patch to redirect the left ventricular outflow into the aortic
root. Enlargement of the defect might be inevitable for this
reason.2 A small restrictive VSD could be enlarged by re-
secting the conal septum or the anterosuperior margin, creat-
ing a straighter left ventricular outflow tract. Moreover,
enlargement of the VSD might reduce the risk of postoper-
ative LVOTO. Persistence of LVOTO might be due to re-
strictive VSD that was not sufficiently enlarged or it might
develop later as a result of outflow tract muscular hypertro-
phy. Another explanation for LVOTO is right ventricular
hypertension caused by conduit stenosis. Septal hypertrophy
and leftward septal displacement will affect the tunnel shape
of the systemic ventricular outflow tract. An abnormal mass/
volume ratio of the systemic ventricle caused by removing
volume overload after the operation is another risk factor
in patients who did not receive the VSD enlargement.2,3 Re-
sidual LVOTO in one of our patients could also be explained
by the lower age at the time of repair. Ho¨rer and colleagues,4
in a retrospective study, reported that age at the time of the
Rastelli operation played an important role in the rate of free-
dom from LVOTO reoperation. Younger age at the time of
Rastelli repair implements its effects through limited resec-
tion of the septum or limited access to create a straight sys-
temic ventricular outflow tract. The higher rate of freedom
from reoperation for LVOTO in our study can be explained
by the higher median age at the time of the Rastelli or Ras-
telli-type operations in our patients (6 vs 3.1 years in the
study by Kreutzer and associates3).
Resection of the interventricular septum, although advan-
tageous, can be the nidus for deleterious effects that result in
early and late morbidity or mortality. The effect of VSD en-
largement in the outcome of the Rastelli operation has been
FIGURE 1. Kaplan–Meier estimated survival for all patients after Rastelli
or Rastelli-type repair.394 The Journal of Thoracic and Cardiovascular Surdifferent in several reported series.2,4,5 In the series reported
by Moulton and coworkers,2 VSD was enlarged in 80% of
their patients without any effect on early or late mortality.
However, similar to our findings, Ho¨rer and colleagues4
found that enlargement of the VSD in 59% of their patients
(57% of our patients) who underwent the Rastelli operation
was a predictor for late death or transplantation. The ques-
tion will arise of whether an alternative procedure, such as
a single-ventricle approach or Nikaidoh aortic transloca-
tion,6 would lead to a better outcome and survival.
Residual VSDs are seen more frequently after VSD en-
largement.7 This could be related to the large patch necessary
to provide unobstructed flow into the aorta. Anomalous ven-
tricular musculature and tricuspid chordae obscuring the
margins of the VSD also increase the risk of a residual de-
fect.2 Although residual septal defects were much more asso-
ciated with VSD enlargement in our series, early or late
reoperation was only necessary in a few cases with important
hemodynamic effects. It has been reported that reoperation
for residual VSD has an adverse effect on long-term survival,
although this could not be confirmed statistically.2
Another deleterious effect of VSD enlargement, which re-
quired early reoperation in our patients, was tricuspid valve
damage. Tricuspid valve damage caused by VSD enlarge-
ment was considered to be all significant new postoperative
tricuspid regurgitation that was identified by means of
FIGURE 2. Actuarial survival curves for patients undergoing Rastelli or
Rastelli-type repair with (group A) and without (group B) VSD enlarge-
ment. The log-rank test showed a significant relation between late death
and VSD enlargement (P ¼ .005).gery c August 2009
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dysfunction and especially in patients whose restriction across
the VSD was secondary to the tricuspid valve tissue. When
restriction across an existing VSD is secondary to the AV
valve tissue, enlargement of this defect might cause loss of
valve function.8 However, the distortion of the valve mecha-
nism occurs more often because of closure of the VSD rather
than its enlargement. Multivariate analysis did not show that
early reoperation for tricuspid valve damage had an adverse
effect on the long-term survival of our patients.
Both supraventricular and ventricular arrhythmias can be
seen with Rastelli-type operations.9 Our study showed that
early transient and late arrhythmias together have a signifi-
cant relation with VSD enlargement. Furthermore, late ar-
rhythmia was a predictor for late death. Although right
ventriculotomy might result in arrhythmogenic potential of
the scar, both groups of our patients were similar for this
myocardial resection.10,11 Tateno and coworkers9 reported
older age at the time of operation as a predictive risk factor
for supraventricular tachyarrhythmia. However, ventricular
tachyarrhythmia or sudden death is also associated with right
ventricular hypertension caused by progressive right ven-
tricular outflow tract stenosis. Because late arrhythmia and
sudden cardiac arrest had a significant effect on patients’
mortality late after Rastelli repair, it is reasonable to monitor
TABLE 5. Predictors for late death
Variable No. Events
P value,
univariate log-
rank test
P value,
multivariate*
Cox regression
VSD enlargement 24 11 0.005 .009
Atrioventricular valve
damagey
7 5 0.006 .08
Morphology of
complete TGA
28 7 0.17
MPA, LPA, RPA, PPA
stenosis, or PA
25 8 0.09 .035
Age at the time
of operation>4 y
39 12 0.10 .86
Body weight at time
of operation>15k g
36 12 0.038 .98
Aortic saturation<69% 16 8 0.008 .037
Total cardiopulmonary
bypass time>190 min
6 4 0.013 .97
Aortic crossclamp
time>100 min
7 4 0.024 .98
Arrhythmia
(sudden death)
3 3 0.10 .034
Late ventricular
dysfunction
9 5 0.01 .039
Permanent
atrioventricular block
7 3 0.078 .25
VSD, Ventricular septal defect; TGA, transposition of the great arteries; MPA, main
pulmonary artery; LPA, left pulmonary artery; RPA, right pulmonary artery; PPA, pe-
ripheral pulmonary arteries; PA, pulmonary atresia. *Only variables with a univariate
P value of .1 or less were entered as candidates into the Cox model. yTricuspid valve.The Journal of Thoracic andthe patients for finding any probable dysrhythmia by using
Holter monitoring. With the increasing use of implantable
cardioverter–defibrillators in younger patients, those chil-
dren who have survived sudden cardiac death or who have
refractory ventricular tachycardia might also benefit from
implantable cardioverter–defibrillator implantation.12
It is speculated that resection of the anterosuperior margin
of the defect carries the potential risk for AV block and scar
tissue as a substrate for the arrhythmia. It is unlikely that re-
section of the anterosuperior margin of the VSD in hearts
with ventricular d-looping directly damages the conduction
tissue because of its position with respect to the septal defect.
However, AV block might occur as a result of trauma to the
artery supplying the His bundle.13 Either transient or perma-
nent AV block occurred in both groups of our study. How-
ever, there was no relation between VSD enlargement and
either complete or transient AV block.
An important cause of late morbidity in this type of
operation would be ventricular failure. Several factors might
contribute to the ventricular dysfunction, including septal
resection, ventriculotomy, prolonged cardiopulmonary
bypass and ischemic time, residual LVOTO, conduit steno-
sis or regurgitation, and arrhythmia. Consequently, the right
ventricle might be affected more than the left ventricle in this
type of operation.
The interventricular septum plays an important role in the
production of stroke volume. VSD enlargement might dis-
turb the structure/function relationship of the septum and
reduce its contribution to the cardiac output of both
ventricles.14 Furthermore, septal resection might affect con-
tractile function through an abnormal interventricular sep-
tum with a large prosthetic component (the VSD baffle).15
It might also damage the septal perforating arteries.13 Right
ventricular hypertension caused by an obstructed conduit
will cause contractile dysfunction by impairing left ventric-
ular filling and leftward septal displacement. Cardiac re-
synchronization therapy with biventricular pacing has been
shown to be a beneficial therapy in pediatric and adolescent
populations after surgical intervention for congenital heart
disease. It has produced acute hemodynamic improvement
in ventricular dysfunction postoperatively. In more chronic
application, cardiac resynchronization therapy has been
shown to improve exercise tolerance and heart failure symp-
toms and most recently to improve survival as a bridge or
alternative to heart transplantation.16
Although univariate analysis identified several factors
that were associated with early death, including lower age
at the time of repair, early ventricular dysfunction, and lon-
ger cardiopulmonary bypass and ischemic time, the multi-
variate Cox model did not establish any independent risk
factor for early death.
Furthermore, numerous variables were associated with
late death in the univariate analysis (Table 5). However, the
multivariate Cox model established 5 important predictorsCardiovascular Surgery c Volume 138, Number 2 395
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emia, pulmonary artery abnormalities, arrhythmia, and late
ventricular dysfunction. Chronic cyanosis caused by the
longer palliative treatment with the consequence of myocar-
dial fibrosis at the time of operation might have a negative
effect on long-term survival.3
Hypoxemia, ventricular outflow tract obstruction, and
volume overloading over a prolonged period might explain
the lower survival rate in our patients (32% at 15 years vs
52% at 20 years in the study by Kreutzer and associates3)
with higher median age (6 vs 3.1 years in the study by Kreut-
zer and associates) at the time of the operation. In the cohort
of Ho¨rer and colleagues,4 there was a trend toward an in-
creased risk for death or transplantation in patients 4 years
of age or older at the time of Rastelli repair. Therefore early
Rastelli repair in infancy is recommended because of im-
proved late outcome and survival. Kreutzer and associates3
and Ho¨rer and colleagues4 showed that longer cardiopulmo-
nary bypass and aortic crossclamp times were predictive fac-
tors for late death or transplantation in the Rastelli operation.
The cardiopulmonary bypass and ischemic times in our se-
ries, although trending higher in the group with VSD en-
largement, were not significantly different between the 2
groups. Hence VSD enlargement could not affect the late
mortality through prolongation of the cardiac arrest time.
Moreover, cardiopulmonary bypass and ischemic times
were not identified as predictors for late death in the multi-
variate analysis in our study. A higher risk for late death in
patients who received VSD enlargement might be explained
by damaging the septal perforating arteries and the conduc-
tive tissues. An interesting comparison will be the one con-
sidering similar populations of patients with restrictive VSD
and comparing patients with VSD enlargement and biven-
tricular Rastelli repair to those with Fontan palliation with-
out VSD enlargement while considering that a restrictive
VSD and consequent subaortic stenosis would be a severe
limitation toward Fontan palliation. Another interesting
comparison would be the Nikaidoh aortic translocation
and biventricular outflow tract reconstruction technique,
which could be applied to patients with DORV or transposi-
tion of the great arteries with VSD who are not candidates
for the arterial switch procedure because of pulmonary (fu-
ture left ventricular outflow tract) obstruction. However,
the outlet septum is also opened into the VSD as a part of
this surgical procedure.6
Limitations
This study encompasses an intermediate period of follow-
up (median, 4 years). Extending the follow-up period almost
surely will affect the outcomes. Furthermore, the retrospective
design of the follow-up and the small ratio of events per vari-
able concerning the end point of death are other limitation of
our study. Patients with malaligned VSD who receive VSD
enlargement without ventriculotomy will be a source of data396 The Journal of Thoracic and Cardiovascular Suthat the exclusive effect of ventricular septal resection could
be evaluated by removing the effect of ventriculotomy.
CONCLUSIONS
Septal resection for creating a straight systemic ventricular
outflow tract in patients undergoing Rastelli-type operations
has a substantial effect on early and late morbidity and is a pre-
dictive factor for long-term mortality. Enlargement of the VSD
has been associated with a higher prevalence of arrhythmia,
late ventricular dysfunction, and residual VSD after Rastelli
procedure. Chronic hypoxemia and pulmonary artery abnor-
malities were other predictors for late death. Hence VSD en-
largement is one of the multiple causes of the late mortality
in patients undergoing Rastelli operations. However, resection
was not associated with an increased requirement for perma-
nent pacemaker implantation. The higher median age of our
patients at the time of the Rastelli operation compared with
that seen in similar studies could explain the lower survival
rate of our patients through prolonged exposure to factors
such as hypoxemia and volume overloading.
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